Company
Theolytics
Breaking the Barrier to Solid Tumours
Also known as Theolytics Ltd.
- Status
- Operatingas of 2026-09-17
- Business model
- B2B
- Headquarters
- Oxford, United Kingdom
- Founded
- 2017
- Legal name
- Theolytics Ltd.
Claim, correct or request removal
Record updated 28 September 2026
About
Theolytics is developing systemically deliverable immunotherapies based on oncolytic adenoviruses designed to break through the barriers of solid tumours.
Funding snapshot
- Total raised
- $31.3MSum of rounds, as of 2026-09-17Source (opens in a new tab)
- Latest round
- Grant2026-03-04
Funding rounds
- Grant
- 2026-03-04
- Grant
- 2024-09-02
- Round, 2024
- $24.5M2024-04-17, Company stated
- Series A
- $6.8M2020-01-07, Company stated
Products
- Other
- THEO-260
- Web
- THEO-260
Loading relationship preview